Amedisys Stock Rises Amid Merger Deadline Extension with UnitedHealth
Amedisys shares rise as the company extends merger deadline with UnitedHealth Group, despite DOJ's attempt to block the $3.3 billion deal.
Topic
AMED
A collection of 4 issues
Amedisys Stock Rises 4% Amid Merger Extension with UnitedHealth
Amedisys sees a 4% stock jump as it extends its $3.3 billion merger deadline with UnitedHealth Group to Dec 31, 2025, navigating regulatory challenges.
Amedisys Shares Climb 4.7% as UnitedHealth Merger Deadline Extended
Amedisys shares surge 4.7% pre-market. UnitedHealth merger faces DOJ antitrust scrutiny. Discover the impact on AMED stock.
Amedisys Waives Termination Rights in UnitedHealth Merger
Amedisys strengthens its merger with UnitedHealth by waiving termination rights, signaling a committed future partnership in healthcare innovation.